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Mycosis Fungoides: A Master of Disguise
Amogh Joshi, DO, Emilee Kurtz, DO and Yehia Mishriki, MD

Department of Medicine, Lehigh Valley Health Network, Allentown Pa.

INTRODUCTION

Mycosis fungoides is the most common form of
cutaneous T cell lymphoma. However, it is still
incredibly rare, with an incidence of approximately
6 cases per 1,000,000. Initial presentation often
mimics more benign dermatologic conditions,
presenting an early diagnostic challenge.

METHODS

A 53 year old male, with no
significant medical history,
presented with a p
 rogressively
worsening body rash. He had
previously been empirically
treated with emollients and
topical h
 ydrocortisone, without
improvement. Physical
Figure 1: Multiple ovoid, elongated
pink plaques found on physical
examination demonstrated
examination, consistent with
Mycosis fungoides.
multiple ovoid, elongated pink
and minimally raised plaques
along the chest wall, abdomen and right medial calf.

© 2019 Lehigh Valley Health Network

RESULTS

Punch biopsy revealed an interstitial infiltrate composed of perivascular
small lymphocytes within a prominent superficial dermal fibroplasia
extending into the dermis. Lymphocytes were predominantly CD4positive with fewer CD8-positive T cells and absent eosinophils.
CD5 staining was preserved but CD7 expression was decreased.
These findings were consistent with mycosis fungoides. Initial
treatment consisted of topical clobetasol and close follow-up.

CONCLUSION

Mycosis fungoides is a mature T cell lymphoma that initially presents
with cutaneous manifestations. Progressively worsening disease can
lead to lymphatic, hematologic and visceral involvement. A low
threshold for biopsy should be maintained for any plaque-like rash
that does not resolve after initial treatment. Patients, with a suspected
early stage diagnosis require initiation on topical therapies and those
with biopsies demonstrating lymphocytic atypia should be followed
closely. Long term surveillance is crucial in staging disease and
appropriately guiding continued therapeutic intervention. Clinicians
must remain particularly cognizant of this cutaneous malignancy that
masquerades as other benign dermatologic conditions.
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